Showing results (1131-1140 of 1,252) with videos related to

Sort By:
Pageof 126
Journal of Pediatric Hematology/Oncology|July 30, 2013
Mentoring in pediatric oncology: a report from the Children's Oncology Group Young Investigator CommitteeAdam S Levy, Kimberly A Pyke-Grimm, Dean A Lee, et al.
The Lancet. Child & Adolescent Health|November 16, 2023
Improving autism identification and support for individuals assigned female at birth: clinical suggestions and research prioritiesMeng-Chuan Lai, Anouck Amestoy, Somer Bishop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2023
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome ComparisonsJavier Oesterheld, William Ferguson, Jacqueline M Kraveka, et al.
Journal of Diabetes and Its Complications|June 12, 2019
No association between fear of hypoglycemia and blood glucose variability in type 1 diabetes: The cross-sectional VARDIA studyPierre Jean Saulnier, Claire Briet, Elise Gand, et al.
Genome Biology|November 17, 2012
Microbiome dynamics of human epidermis following skin barrier disruptionPatrick L J M Zeeuwen, Jos Boekhorst, Ellen H van den Bogaard, et al.
Diabetologia|January 24, 2024
QRS-T angle: is it a specific parameter associated with sudden cardiac death in type 2 diabetes? Results from the SURDIAGENE and the Mini-Finland prospective cohortsRodrigue Garcia, Linda C Schröder, Marine Tavernier, et al.
Acta Neuropathologica|September 25, 2015
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypesDavid Castel, Cathy Philippe, Raphaël Calmon, et al.
BMC Psychiatry|June 10, 2018
Study protocol for The Emory 3q29 Project: evaluation of neurodevelopmental, psychiatric, and medical symptoms in 3q29 deletion syndromeMelissa M Murphy, T Lindsey Burrell, Joseph F Cubells, et al.
International Journal of Cancer|May 12, 2020
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastomaElizabeth C Lewis, Jacqueline M Kraveka, William Ferguson, et al.
Scientific Reports|September 11, 2020
Connectivity mapping of glomerular proteins identifies dimethylaminoparthenolide as a new inhibitor of diabetic kidney diseaseJulie Klein, Cécile Caubet, Mylène Camus, et al.
Pageof 126